RECRUITING

EMST in Patients Undergoing CRT for HNCA

Description

This study is a randomized trial examining the impact of expiratory muscle strength training (EMST) on maintenance of safe and efficient oropharyngeal swallow function in persons with cancer of the head and neck (HNCA) undergoing treatment with radiation therapy or chemoradiotherapy (RT/CRT).

Conditions

Head and Neck NeoplasmsDeglutition Disorders
Talk to us

Related Conditions:

Head and Neck NeoplasmsDeglutition Disorders

Study Overview

On this page

Study Details

Study overview

This study is a randomized trial examining the impact of expiratory muscle strength training (EMST) on maintenance of safe and efficient oropharyngeal swallow function in persons with cancer of the head and neck (HNCA) undergoing treatment with radiation therapy or chemoradiotherapy (RT/CRT).

Impact of Expiratory Muscle Strength Training (EMST) on Swallowing Function in Persons Undergoing Radiotherapy With or Without Chemotherapy (CRT) for Cancers of the Head and Neck (HNCA)

EMST in Patients Undergoing CRT for HNCA

Condition
Head and Neck Neoplasms
Intervention / Treatment

-

Contacts and Locations

Milwaukee

University of Wisconsin Milwaukee, Milwaukee, Wisconsin, United States, 53211

Milwaukee

Froedtert Hospital, Milwaukee, Wisconsin, United States, 53226

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * New diagnosis of cancer in the oral cavity, oropharynx, hypopharynx, or larynx;
  • * Planned treatment with primary radiotherapy with or without chemotherapy;
  • * Age 18 or older and able to provide consent;
  • * Ability to use the EMST150 device (hold in mouth and maintain lip seal)
  • * Primary surgery to the head and neck (neck dissection is permitted);
  • * Unknown primary tumor;
  • * Primary cancers of the nasopharynx, paranasal sinuses, salivary glands and skin.
  • * Progressive neurologic condition affecting muscle strength (e.g. amyotrophic lateral sclerosis (ALS), Parkinson's disease)
  • * Dysphagia not related to HNCA (e.g. unresolved swallowing difficulty post-stroke or post--traumatic brain injury (TBI))
  • * Prior history of head and neck radiotherapy

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Wisconsin, Milwaukee,

Barbara Pauloski, PRINCIPAL_INVESTIGATOR, University of Wisconsin, Milwaukee

Study Record Dates

2025-08-01